bexagliflozin

Term ID

CHEBI:229225

Synonyms

(1S)-1,5-anhydro-1-(4-chloro-3-{4-[2-(cyclopropyloxy)ethoxy]benzyl}phenyl)-D-glucitol
(1S)-1,5-anhydro-1-C-[4-chloro-3-[[4-[2-(cyclopropyloxy)ethoxy]phenyl]methyl]phenyl]-D-glucitol
(2S,3R,4R,5S,6R)-2-(4-chloro-3-{4-[2-(cyclopropyloxy)ethoxy]benzyl}phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
(2S,3R,4R,5S,6R)-2-[4-chloro-3-({4-[2-(cyclopropyloxy)ethoxy]phenyl}methyl)phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
bexagliflozin
bexagliflozina
bexagliflozine
bexagliflozinum
Brenzavvy
EGT 1442
EGT-1442
EGT0001442
EGT1442
THR 1442
THR-1442
THR1442

Definition

A C-glycosyl comprising of beta-D-glucose in which the anomeric hydroxy group is replaced by a 4-chloro-3-({4-[2-(cyclopropyloxy)ethoxy]phenyl}methyl)phenyl group. It is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: aromatic ether C-glycosyl compound cyclopropanes diether monochlorobenzenes

aromatic ether C-glycosyl compound cyclopropanes diether monochlorobenzenes Show first 5 Terms
has_role: antihypertensive agent hypoglycemic agent sodium-glucose transport protein subtype 2 inhibitor

antihypertensive agent hypoglycemic agent sodium-glucose transport protein subtype 2 inhibitor Show first 5 Terms

Phenotype

Phenotype resulting from bexagliflozin

Phenotype where environments contain bexagliflozin

Phenotype modified by environments containing bexagliflozin

Human Disease Model